These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 30918245)
1. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Chen L; Chen DQ; Liu JR; Zhang J; Vaziri ND; Zhuang S; Chen H; Feng YL; Guo Y; Zhao YY Exp Mol Med; 2019 Mar; 51(3):1-18. PubMed ID: 30918245 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of fecal microbiome and metabolome during renal fibrotic progression in a unilateral ureteral obstruction animal model. Hu X; Xie Y; Xiao Y; Zeng W; Gong Z; Du J Eur J Pharmacol; 2020 Nov; 886():173555. PubMed ID: 32937112 [TBL] [Abstract][Full Text] [Related]
3. [Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction]. Zhao DA; Liu J; Huang Q; Han ZM Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):903-8. PubMed ID: 24131846 [TBL] [Abstract][Full Text] [Related]
4. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill. Chen R; Wang J; Zhan R; Zhang L; Wang X J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318 [TBL] [Abstract][Full Text] [Related]
5. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Feng YL; Cao G; Chen DQ; Vaziri ND; Chen L; Zhang J; Wang M; Guo Y; Zhao YY Cell Mol Life Sci; 2019 Dec; 76(24):4961-4978. PubMed ID: 31147751 [TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction. Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820 [TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats. Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438 [TBL] [Abstract][Full Text] [Related]
8. [The expression of AT1A receptor and its modulation by benazepril in the renal tubulointerstitial lesions induced by ureteral obstruction]. Chen X; Shi S; Li W Zhonghua Yi Xue Za Zhi; 1997 Apr; 77(4):245-8. PubMed ID: 9596920 [TBL] [Abstract][Full Text] [Related]
9. FuZhengHuaYuJiangZhuTongLuoFang Prescription Modulates Gut Microbiota and Gut-Derived Metabolites in UUO Rats. Chen Z; Wu S; Zeng Y; Chen Z; Li X; Li J; He L; Chen M Front Cell Infect Microbiol; 2022; 12():837205. PubMed ID: 35669118 [TBL] [Abstract][Full Text] [Related]
10. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590 [TBL] [Abstract][Full Text] [Related]
11. Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy. Li A; Zhang X; Shu M; Wu M; Wang J; Zhang J; Wang R; Li P; Wang Y Phytomedicine; 2017 Jul; 30():28-41. PubMed ID: 28545667 [TBL] [Abstract][Full Text] [Related]
12. Kangxianling formula attenuates renal fibrosis by regulating gut microbiota. Tao P; Liu H; Hou G; Lu J; Xu Y Eur J Med Res; 2024 Mar; 29(1):183. PubMed ID: 38500195 [TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney. Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137 [TBL] [Abstract][Full Text] [Related]
14. 1H NMR-based metabonomics study on serum of renal interstitial fibrosis rats induced by unilateral ureteral obstruction. Zhang H; Jia J; Cheng J; Ye F; Li X; Gao H Mol Biosyst; 2012 Feb; 8(2):595-601. PubMed ID: 22027911 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Mizuno S; Matsumoto K; Nakamura T Kidney Int; 2001 Apr; 59(4):1304-14. PubMed ID: 11260391 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb1, a panoxadiol saponin against oxidative damage and renal interstitial fibrosis in rats with unilateral ureteral obstruction. Xie XS; Liu HC; Yang M; Zuo C; Deng Y; Fan JM Chin J Integr Med; 2009 Apr; 15(2):133-40. PubMed ID: 19407952 [TBL] [Abstract][Full Text] [Related]
17. Ulinastatin inhibits renal tubular epithelial apoptosis and interstitial fibrosis in rats with unilateral ureteral obstruction. Zhang QF Mol Med Rep; 2017 Dec; 16(6):8916-8922. PubMed ID: 28990075 [TBL] [Abstract][Full Text] [Related]
18. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250 [TBL] [Abstract][Full Text] [Related]
19. Artesunate attenuates unilateral ureteral obstruction-induced renal fibrosis by regulating the expressions of bone morphogenetic protein-7 and uterine sensitization-associated gene-1 in rats. Cao J; Wang W; Li Y; Xia J; Peng Y; Zhang Y; Xia A Int Urol Nephrol; 2016 Apr; 48(4):619-29. PubMed ID: 26865179 [TBL] [Abstract][Full Text] [Related]